Watchlist Price Alert

Cocrystal Pharma Inc. (COCP)

NASDAQ: COCP · Real-Time Price · USD

1.57

-0.02 (-1.26%)

At close: Jun 18, 2025, 12:31 PM

Cocrystal Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	2.01M	6.56M	n/a	n/a	n/a
Cost of Revenue	n/a	15.17K	241.6K	239.5K	238.9K	4K	50K	101K	201K
Gross Profit	n/a	-15.17M	-241.6K	-239.5K	1.78M	6.56M	-50K	-101K	-201K
Operating Income	-17.88M	-21.16M	-38.83M	-14.22M	-9.59M	-48.41M	-62.92M	-8.26M	-105.82M
Interest Income	n/a	n/a	2.00	4.00	8.00	19.00	n/a	n/a	126K
Pretax Income	-17.5M	-17.98M	-38.84M	-14.19M	-9.65M	-48.17M	-62.63M	-7.49M	-104.27M
Net Income	-17.5M	-17.98M	-38.84M	-14.19M	-9.66M	-48.19M	-49.05M	-613K	-74.87M
Selling & General & Admin	5.34M	5.99M	5.75M	5.43M	5.29M	4.86M	4.35M	2.44M	4.14M
Research & Development	12.54M	15.17M	12.39M	8.79M	6.31M	4M	58.57M	5.82M	101.68M
Other Expenses	n/a	-2.6M	20.69M	n/a	n/a	n/a	n/a	-131K	-1K
Operating Expenses	17.88M	18.56M	17.75M	14.22M	11.6M	8.87M	62.92M	8.26M	105.82M
Interest Expense	n/a	n/a	2K	4K	8K	19K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.88M	18.56M	18.14M	14.22M	11.6M	8.87M	62.92M	8.26M	105.82M
Income Tax Expense	n/a	n/a	8K	4K	8K	19K	-13.58M	-6.88M	-29.39M
Shares Outstanding (Basic)	10.17M	9.65M	8.14M	88.37M	55.22M	31.86M	2.33M	2.01M	1.96M
Shares Outstanding (Diluted)	10.17M	9.65M	8.14M	88.37M	55.22M	31.86M	2.33M	2.01M	1.96M
EPS (Basic)	-1.72	-0.00	-4.77	-0.16	-0.17	-1.51	-21.01	-0.3	-38.17
EPS (Diluted)	-1.72	-0.00	-4.77	-0.16	-0.17	-1.51	-21.01	-0.3	-38.14
EBITDA	-17.43M	-19.37M	-17.75M	-13.8M	-9.3M	-47.9M	-62.52M	-7.39M	-105.62M
EBIT	-17.88M	-17.98M	-38.84M	-14.18M	-9.64M	-48.15M	-62.57M	-7.49M	-105.82M
Depreciation & Amortization	446K	-1.39M	388K	382K	336K	254K	50K	101K	201K